| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/05/2015 | US20150065450 Compound of glycosaminoglycan and its preparation method as well as application |
| 03/05/2015 | US20150065449 Treating Amyloidoses With A Vitamin B12 Composition Including Melatonin, Resveratrol, and EGCG |
| 03/05/2015 | US20150065448 Methods of treating amyloidoses with vitamin b12 and diagnostic test for detecting the presence of amyloid-beta peptides |
| 03/05/2015 | US20150065447 Survival benefit in patients with solid tumors with elevated c-reactive protein levels |
| 03/05/2015 | US20150065446 Compound of glycosaminoglycan and its fabrication method as well as application |
| 03/05/2015 | US20150065445 Viral Polymerase Inhibitors |
| 03/05/2015 | US20150065444 Method for enhancing efficacy and selectivity of cancer cell killing by dna damaging agents |
| 03/05/2015 | US20150065443 Embelin-based delivery system for water-insoluble active agents |
| 03/05/2015 | US20150065442 Reducible self-assembled micelle drug delivery systems |
| 03/05/2015 | US20150065441 Pharmaceutical composition for prevention or treatment of cognitive function disorders comprising spinosyn |
| 03/05/2015 | US20150065439 Pharmaceutical compositions |
| 03/05/2015 | US20150065438 Prepackaged sterile syringe or containers with various substance concentrations with or without bioactive reagent |
| 03/05/2015 | US20150065432 Visfatin therapeutic agents for the treatment of acne and other conditions |
| 03/05/2015 | US20150065431 Reducing cutaneous scar formation and treating skin conditions |
| 03/05/2015 | US20150065427 Modulation of osteoclast differentiation |
| 03/05/2015 | US20150065426 Testosterone Booster Transdermal Compositions |
| 03/05/2015 | US20150065423 Rapid acting injectable formulations |
| 03/05/2015 | US20150065418 Neuregulin based methods and compositions for treating cardiovascular diseases |
| 03/05/2015 | US20150065416 Novel drug combination |
| 03/05/2015 | US20150065415 Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
| 03/05/2015 | US20150064288 Anti-Microbial Composition |
| 03/05/2015 | US20150064287 Method for treating abnormal polyglutamine-mediated diseases |
| 03/05/2015 | US20150064285 Slow release magnesium composition and uses thereof |
| 03/05/2015 | US20150064284 Methods for preventing or treating infectious diseases caused by extracellular microorganisms, including antimicrobial-resistant strains thereof, using gallium compounds |
| 03/05/2015 | US20150064283 Pharmaceutical compositions for parenteral administration |
| 03/05/2015 | US20150064282 Use of neu1 sialidase inhibitors in the treatment of cancer |
| 03/05/2015 | US20150064281 Ophthalmic composition |
| 03/05/2015 | US20150064268 Nanoparticles for stimulating elastogenesis |
| 03/05/2015 | US20150064266 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| 03/05/2015 | US20150064264 Pharmaceutical dosage forms comprising a low-solubility drug and a polymer |
| 03/05/2015 | US20150064263 Compositions and methods for reduction of mercury toxicity |
| 03/05/2015 | US20150064262 Nitazoxadine composition and process to prepare same |
| 03/05/2015 | US20150064261 Multiparticulate L-Menthol Formulations and Related Methods |
| 03/05/2015 | US20150064258 Diclofenac formulations and methods of use |
| 03/05/2015 | US20150064254 Method for treatment of pain and inflammation |
| 03/05/2015 | US20150064253 Combination formulation of two antiviral compounds |
| 03/05/2015 | US20150064252 Solid dispersion formulation of an antiviral compound |
| 03/05/2015 | US20150064251 Tamper Resistant Dosage Form Composition And Process Of Making The Same |
| 03/05/2015 | US20150064250 Tamper-Resistant Pharmaceutical Dosage Forms |
| 03/05/2015 | US20150064249 Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
| 03/05/2015 | US20150064248 Abuse resistant forms of extended release hydromorphone, method of use and method of making |
| 03/05/2015 | US20150064247 Abuse resistant forms of immediate release hydrocodone, method of use and method of making |
| 03/05/2015 | US20150064246 Abuse resistant forms of extended release oxymorphone, method of use and method of making |
| 03/05/2015 | US20150064245 Abuse Resistant Forms of Immediate Release Hydromorphone, Method of Use and Method of Making |
| 03/05/2015 | US20150064244 Konjac formulation and method for preparing the same |
| 03/05/2015 | US20150064243 Pharmaceutical compositions and dosage forms for admininistration of hydrophobic drugs |
| 03/05/2015 | US20150064242 Trialkyl cationic lipids and methods of use thereof |
| 03/05/2015 | US20150064238 Method and composition for enhancing the delivery of anti-platelet drugs for the treatment of acute stroke |
| 03/05/2015 | US20150064236 Modified polynucleotides for the production of proteins |
| 03/05/2015 | US20150064234 4-aminopyridine as a therapeutic agent for spinal muscular atrophy |
| 03/05/2015 | US20150064232 Transdermal absorption preparation |
| 03/05/2015 | US20150064231 Oral film containing opiate enteric-release beads |
| 03/05/2015 | US20150064230 Sustained release delivery of one or more agents |
| 03/05/2015 | US20150064223 Biguanide Compositions and Methods of Treating Metabolic Disorders |
| 03/05/2015 | US20150064222 Nutritional compositions for enhancing immune function |
| 03/05/2015 | US20150064220 Methods for modulating cell-mediated immunity using human milk oligosaccharides |
| 03/05/2015 | US20150064200 Methods and compositions for 6-phosphogluconate dehydrogenase (6-pgd) as a target for lung cancer therapy |
| 03/05/2015 | US20150064199 Cancer therapy using beta glucan and antibodies |
| 03/05/2015 | US20150064196 Substituted Hetero-Bicyclic Compounds, Compositions and Medicinal Applications Thereof |
| 03/05/2015 | US20150064189 Method of Treating Cancer with DLL4 Antagonist and Chemotherapeutic Agent |
| 03/05/2015 | US20150064181 Antisense conjugates for decreasing expression of dmpk |
| 03/05/2015 | US20150064180 Combination therapy with cd4 lymphocyte depletion and mtor inhibitors |
| 03/05/2015 | US20150064175 Pfkfb3 inhibitor and methods of use as an anti-cancer therapeutic |
| 03/05/2015 | US20150064173 Methods of treating a disease or disorder associated with bruton's tyrosine kinase |
| 03/05/2015 | US20150064172 Methods of treating a disease or disorder associated with bruton's tyrosine kinase |
| 03/05/2015 | US20150064171 Combinations of akt inhibitor compounds and chemotheraeptuc agents, and methods of use |
| 03/05/2015 | US20150064168 Cadherin-11 Inhibitors and Methods of Use Thereof |
| 03/05/2015 | US20150064165 Devices and methods for reducing the appearance of cellulite |
| 03/05/2015 | US20150064143 Ionically cross-linkable alginate-grafted hyaluronate compound |
| 03/05/2015 | US20150064135 Agent for the treatment of viral hepatitis c |
| 03/05/2015 | US20150064132 Treatment Methods for Rheumatoid Arthritis |
| 03/05/2015 | US20150064131 Pharmaceutical compositions comprising polymeric binders with non-hydrolysable covalent bonds and their use in treating celiac disease |
| 03/05/2015 | US20150064129 Wound healing composition |
| 03/05/2015 | US20150064127 4-oxo-2-pentenoic acid and skin pigmentation |
| 03/05/2015 | US20150064126 Use of chitosans for the treatment of nail inflammatory diseases |
| 03/05/2015 | US20150064114 Liposome including hydrophobic material and imaging agent and use of the liposome |
| 03/05/2015 | DE102013109514A1 Reduktion der Zelltoxizität von Bakteriostatika mittels Farbstoffen Reduction of cell toxicity of antimicrobials using dyes |
| 03/05/2015 | DE102013014417A1 Schwammkollagen umfassende Zubereitungen mit definiertem in vivo-Freisetzungsprofil vor allem im Colon, deren Herstellung und Verwendung Collagen sponge comprehensive preparations defined in vivo release profile especially in the colon, their preparation and use |
| 03/04/2015 | EP2843049A1 Neuronal differentiation promoter |
| 03/04/2015 | EP2842961A1 New carbamate glycolipid and use thereof |
| 03/04/2015 | EP2842957A1 Method for extracting and separating ginkgolides |
| 03/04/2015 | EP2842956A1 PARP inhibitor compounds, compositions and methods of use |
| 03/04/2015 | EP2842955A1 Trk-INHIBITING COMPOUND |
| 03/04/2015 | EP2842952A1 Method for producing zaltoprofen and derivative thereof |
| 03/04/2015 | EP2842950A1 Method for producing composition containing fucoxanthin |
| 03/04/2015 | EP2842949A1 Analogues of porphyrins, their method of preparation and use thereof especially in dye-sensitive solar cells |
| 03/04/2015 | EP2842948A1 Novel compounds and compositions and methods of use |
| 03/04/2015 | EP2842946A1 Quinazolinedione derivative |
| 03/04/2015 | EP2842945A1 Sulfonamide derivative and medicinal use thereof |
| 03/04/2015 | EP2842942A1 Trans-2-decenoic acid derivative and drug containing same |
| 03/04/2015 | EP2842940A1 Sulforaphane-derived compounds, production method thereof and the medical, food and cosmetic use of same |
| 03/04/2015 | EP2842939A1 Benzamide derivative |
| 03/04/2015 | EP2842938A1 Novel beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient |
| 03/04/2015 | EP2842937A1 Amine compound and use thereof for medical purposes |
| 03/04/2015 | EP2842933A1 Mixtures of cannabinoid compounds, their preparation and use |
| 03/04/2015 | EP2842931A1 4-((substituted phenyl) difluoromethyl) phenoxy carboxylic acid derivative, and preparation method and uses thereof |
| 03/04/2015 | EP2842605A2 Use of non-peptide nk1 receptor antagonists for the production of apoptosis in tumor cells |
| 03/04/2015 | EP2842577A1 Method for proliferating cardiomyocytes using micro-RNA |
| 03/04/2015 | EP2842568A1 Pharmaceutical composition for treating and/or preventing type i diabetes and application thereof |
| 03/04/2015 | EP2842563A1 A composition comprising powdered eggshell membrane for use in treating a pre-diabetic mammals. |